Equities

OPKO Health Inc

OPKO Health Inc

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.57
  • Today's Change0.01 / 0.64%
  • Shares traded656.15k
  • 1 Year change+2.61%
  • Beta1.6301
Data delayed at least 15 minutes, as of Nov 22 2024 16:50 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The Company focuses on leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. Its segments include pharmaceutical and diagnostics. The pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel and Spain, Rayaldee product sales and its pharmaceutical research and development. The diagnostics segment primarily consists of point-of-care operations. Its pharmaceutical business features Rayaldee, a United States Food and Drug Administration (FDA) approved treatment for secondary hyperparathyroidism (SHPT) in adults with stage three or four chronic kidney disease (CKD) and vitamin D insufficiency, and Somatrogon (hGH-CTP), a once-weekly human growth hormone injection. Its NGENLA (somatrogon-ghla), is a once-weekly, human growth hormone analog indicated for treatment of pediatric patients aged three years and older.

  • Revenue in USD (TTM)711.41m
  • Net income in USD-133.73m
  • Incorporated1991
  • Employees3.93k
  • Location
    OPKO Health Inc4400 Biscayne Blvd.MIAMI 33137United StatesUSA
  • Phone+1 (305) 575-4181
  • Websitehttps://www.opko.com/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Talkspace Inc181.29m-1.37m559.13m472.00--4.75--3.08-0.0085-0.00851.070.69651.30--20.63384,091.10-0.985---1.15--47.04---0.7568------0.00--25.49--75.92------
InnovAge Holding Corp786.51m-15.96m627.35m2.35k--2.40279.940.7976-0.1175-0.11755.791.931.47--17.30334,686.00-3.35-3.72-4.76-4.9017.6420.39-2.28-2.79---2.300.2172--11.0110.4147.54---11.39--
Agilon Health Inc5.35bn-306.78m733.39m1.12k--1.28--0.137-0.7574-0.952113.131.402.45--3.954,792,792.00-14.04---36.97--2.00---5.73------0.0572--80.74---112.01------
QDM International Inc3.93m1.30m790.14m5.00606.26180.97587.92201.150.00450.00450.01350.0150.5994--21.84785,618.0019.86--34.36--61.80--33.13----436.130.2444--461.81--3,411.87------
AMN Healthcare Services, Inc.3.07bn53.04m978.49m3.59k18.511.104.280.3191.391.3980.2523.431.15--4.86855,604.201.999.322.5912.4131.3432.961.736.62--2.000.55940.00-27.7312.15-52.568.2523.70--
Pennant Group Inc652.30m21.15m1.05bn5.79k44.345.4637.491.610.68790.687921.255.591.12--9.10112,640.603.831.814.542.1420.5521.623.421.92--4.240.36760.0015.1413.76101.40-3.1314.07--
Brookdale Senior Living, Inc.3.10bn-209.17m1.06bn25.20k--3.637.020.3426-0.924-0.92413.681.470.5267--61.66122,977.10-3.56-2.20-4.07-2.4825.6821.71-6.75-4.40--0.25340.9361--6.74-7.8220.73---12.60--
OPKO Health Inc711.41m-133.73m1.06bn3.93k--0.7586--1.50-0.1831-0.18310.99832.060.32998.306.35181,019.80-6.20-7.14-6.86-8.1425.1034.42-18.80-13.832.69-5.360.2418---14.01-2.7042.49---10.19--
Aveanna Healthcare Holdings Inc1.98bn-65.85m1.12bn3.50k------0.565-0.3438-0.343810.26-0.80211.20--7.56566,707.10-3.99---5.21--30.8731.12-3.32-12.71--0.79061.12--6.028.6279.68---20.76--
Pediatrix Medical Group Inc2.01bn-253.84m1.27bn2.90k--1.73--0.6312-3.07-3.0724.078.530.9116--7.11692,068.30-11.530.8579-13.800.9945-----12.651.52--4.840.46110.001.152.97-196.55--14.25--
Progyny Inc1.14bn57.27m1.35bn563.0025.813.0422.441.190.58010.580111.574.921.64--4.142,022,611.008.2611.5011.6316.0221.6821.485.036.64----0.000.0038.3459.52104.35--44.47--
US Physical Therapy Inc645.70m14.10m1.46bn3.90k103.663.0329.912.270.93520.935242.9332.020.6332--8.70165,606.303.127.134.3110.6419.4121.964.939.71--45.420.175358.539.345.91-38.011.785.2613.33
Data as of Nov 22 2024. Currency figures normalised to OPKO Health Inc's reporting currency: US Dollar USD

Institutional shareholders

21.44%Per cent of shares held by top holders
HolderShares% Held
Rubric Capital Management LPas of 30 Sep 202448.71m6.98%
The Vanguard Group, Inc.as of 30 Sep 202428.62m4.10%
BlackRock Fund Advisorsas of 30 Sep 202425.75m3.69%
KSM Mutual Funds Ltd.as of 31 Jul 20249.41m1.35%
SSgA Funds Management, Inc.as of 30 Sep 20248.72m1.25%
Geode Capital Management LLCas of 30 Sep 20248.37m1.20%
Migdal Mutual Funds Ltd.as of 31 Jul 20246.23m0.89%
Invesco Capital Management LLCas of 30 Sep 20246.02m0.86%
Charles Schwab Investment Management, Inc.as of 30 Sep 20244.21m0.60%
Northern Trust Investments, Inc.(Investment Management)as of 30 Sep 20243.48m0.50%
More ▼
Data from 31 Jul 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.